Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer
BackgroundTriple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. Although ligand–receptor (LR) interactions play a crucial role in intercellular communication and contribute to tumor heterogeneity, their molecular details and potential as prognos...
Saved in:
| Main Authors: | Chuanzhi Chen, Jiahui Qi, Weichao Lin, Chunlan Fu, Xin Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1590951/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer
by: Zhideng Yan, et al.
Published: (2024-12-01) -
Construction of a stromal cell-related prognostic signature based on a 101-combination machine learning framework for predicting prognosis and immunotherapy response in triple-negative breast cancer
by: Fanrong Li, et al.
Published: (2025-05-01) -
Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-03-01) -
Identification of circulating tumor cells marker genes as prognostic signature in triple-negative breast cancer
by: Jia Hu, et al.
Published: (2025-05-01) -
Tumor neoantigens as key drivers of significant anti - tumor immunity in triple - negative breast cancer mouse models
by: Yujeong Her, et al.
Published: (2025-09-01)